Clinical Trials Nct Page
Clinical Trial Results:
A randomized phase III study of follow-up with or without Gefitinib (IressaTM) following chemotherapy in patients with advanced non-small cell lung cancer.
| Summary | |
EudraCT number | 2004-001331-36 |
Trial protocol | IT GB |
Global completion date | 02 Dec 2009 |
| Paediatric regulatory details | |
Is the trial part of an agreed EMA paediatric investigation plan? | No |
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? | No |
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? | No |
| Results information | |
Results version number | v1(current) |
This version publication date | 29 Mar 2017 |
First version publication date | 29 Mar 2017 |
Other versions | |
Summary report(s) | 08021 short report |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03 for further information.